Contents

Current Drug Targets - CNS & Neurological Disorders, Volume 4 - Number 3

Editorial [Hot Topic: Amyloid-Associated Disease Mechanisms in Alzheimers Disease (Guest Editor: Jeroen J.M. Hoozemans)]

, 4(3): 221 - 222

Jeroen J.M. Hoozemans


DOI: 10.2174/1568007054038193




The Neuroinflammatory Response in Plaques and Amyloid Angiopathy in Alzheimers Disease: Therapeutic Implications

, 4(3): 223 - 233

Annemieke J.M. Rozemuller, Willem A van Gool and Piet Eikelenboom


DOI: 10.2174/1568007054038229




Amyloid Associated Proteins in Alzheimers and Prion Disease

, 4(3): 235 - 248

R. Veerhuis, R. S. Boshuizen and A. Familian


DOI: 10.2174/1568007054038184




Preventing Activation of Receptor for Advanced Glycation Endproducts in Alzheimers Disease

, 4(3): 249 - 266

L- F. Lue, S. D. Yan, D. M. Stern and D. G. Walker


DOI: 10.2174/1568007054038210




The Nrf2-ARE Signalling Pathway: Promising Drug Target to Combat Oxidative Stress in Neurodegenerative Disorders

, 4(3): 267 - 281

Freek L. van Muiswinkel and H. Bea Kuiperij


DOI: 10.2174/1568007054038238




Protein Quality Control in Alzheimers Disease: A Fatal Saviour

, 4(3): 283 - 292

W. Scheper and E. M. Hol


DOI: 10.2174/1568007054038166




The Expression of Cell Cycle Proteins in Neurons and its Relevance for Alzheimers Disease

, 4(3): 293 - 306

Uwe Ueberham and Thomas Arendt


DOI: 10.2174/1568007054038175




The Role of COX-1 and COX-2 in Alzheimers Disease Pathology and the Therapeutic Potentials of Non-Steroidal Anti-Inflammatory Drugs

, 4(3): 307 - 315

Jeroen J.M. Hoozemans and M. Kerry O'Banion


DOI: 10.2174/1568007054038201




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science